Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primaquine bioequivalence study
PACTR202111661886287Phase 1Completed
- Sponsor
- University of Oxford
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of primaquine (2 arms), sponsored by University of Oxford. Primary endpoints: Cmax, AUCt and 5 more. Started Feb 2024; status: completed.
02
Drugs
primaquine
Beyond the preview
Go deeper on PACTR202111661886287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202111661886287.